Structure-Activity Study of an All-d Antimicrobial Octapeptide D2D

Area of Science:

• Biochemistry
• Microbiology
• Medicinal Chemistry

Background:

• Multi-drug resistant bacteria pose a significant global public health threat.
• Antimicrobial peptides (AMPs) are a crucial component of the innate immune system and a promising alternative to conventional antibiotics.
• A previously identified octapeptide amide, D2D, demonstrated notable antimicrobial activity.

Purpose of the Study:

• To conduct a structure-activity relationship (SAR) study of the AMP D2D.
• To identify key structural elements responsible for antimicrobial efficacy and potential toxicity.
• To discover novel analogues with improved antimicrobial properties.

Main Methods:

• Synthesis and evaluation of 36 D2D analogues.
• Structure-activity relationship analysis including alanine scanning, hydrophobicity variation, amphipathicity manipulation, terminal deletions, and charge substitutions.
• Antimicrobial activity testing (MIC determination, time-kill kinetics), hemolytic activity assays, Circular Dichroism (CD) spectroscopy, and Small-Angle X-ray Scattering (SAXS) for structural and biophysical characterization.

Main Results:

• Hydrophobic residues at positions 3, 4, 6, and 8 were critical for antimicrobial activity, with cationic lysine residues also playing a role.
• Analogue 5 exhibited potent activity (MIC of 4 µg/mL) against *A. baumannii*, *E. coli*, *P. aeruginosa*, and *S. aureus*, with 47% hemolytic activity.
• CD spectra indicated an α-helical secondary structure propensity, while SAXS revealed diverse structural models (random coil, nanotube, filament-like) for different analogues, with analogue 5 forming nanotubes and showing enhanced lipid bilayer insertion compared to D2D.

Conclusions:

• The study elucidated critical structural determinants for the antimicrobial activity of D2D analogues.
• Analogue 5 emerged as a promising candidate with potent broad-spectrum activity and unique nanotube-forming properties.
• While D2D remains a lead compound, analogue 5 warrants further investigation for its therapeutic potential against drug-resistant bacteria.